Volume 28 - Issue 1

Research Article Biomedical Science and Research Biomedical Science and Research CC by Creative Commons, CC-BY

A Systematic Analysis of the Role of Elastography in Assessing Muscle Health

*Corresponding author:Atul Kapoor, Department of Radiology, Advanced Diagnostics, Amritsar, Punjab, India.

Received:August 08, 2025; Published:August 18, 2025

DOI: 10.34297/AJBSR.2025.28.003648

Abstract

Aim: Sarcopenia impacts 10-16% of older adults globally. Conventional diagnostic approaches face challenges in evaluating muscle quality. This systematic review assessed the effectiveness of Shear Wave Elastography (SWE) in distinguishing between muscle health indicators and in diagnosing sarcopenia.
Methods: A systematic review of 42 studies encompassing 11,025 participants from to 2020-2025. We examined SWE measurements using a random- effects meta-analysis.
Results: SWE demonstrated exceptional diagnostic accuracy: AUC 0.951 (95 % CI: 0.923-0.973), sensitivity 85.2 % (95 % CI: 79.1-90.1 %), and specificity 91.4 % (95 % CI: 86.8-94.8 %). Normal aging showed increased stiffness (r = +0.48, p<0.001), whereas sarcopenia showed decreased stiffness (r = -0.52, p<0.001). Minimal publication bias (Egger’s test, p = 0.081) was observed in this study.
Conclusions: Elastography is a transformative diagnostic tool with high clinical-grade accuracy for differentiating normal muscle aging from sarcopenia.

Keywords:Elastography, Sarcopenia, Muscle aging, Shear wave elastography, Diagnostic accuracy

Introduction

By 2050, 21 % of the global population will be over 60 years of age, making age-related conditions a significant public health concern [1,2]. Sarcopenia refers to the gradual decline in skeletal muscle mass, strength, and function with age [3,4]. This condition encompasses complex changes in the muscle architecture and biomechanical properties that compromise physical performance [5]. Current studies indicate sarcopenia impacts 10-16 % of older adults worldwide, with the prevalence differing significantly according to diagnostic criteria [6,7]. Normal aging and pathological sarcopenia represent distinct processes: normal aging increases passive stiffness through collagen accumulation [8,9] whereas sarcopenia decreases stiffness due to muscle mass loss and architectural disruption [10,11,94,95]. Dual-energy X-ray Absorptiometry (DXA) is affected by fluid status and provides limited muscle quali ty information [12,13]. Bioelectrical Impedance Analysis (BIA) has poor accuracy [14,15]. CT and MRI are expensive and impractical for routine screening [16,17]. Shear Wave Elastography (SWE) uses acoustic radiation force impulses to generate shear waves with propagation velocities related to tissue stiffness [18]. This offers non-invasive real-time measurements, objective stiffness values, cost-effectiveness, and excellent reproducibility [19-22]. This review aimed to evaluate the diagnostic accuracy of elastography for sarcopenia detection and examine age-related changes in muscle elasticity parameters.

Methods

Search Strategy

A systematic search was performed using PubMed, EMBASE, Web of Science, and Cochrane Library from January 2020 to July 2025, following the PRISMA guidelines. Search combined: (Elastography OR shear wave elastography) AND (muscle OR sarcopenia OR aging) AND (diagnosis OR assessment).

Inclusion/Exclusion Criteria

The inclusion criteria were human participants aged ≥18 years, using elastography for muscle assessment, English language, and peer-reviewed articles with quantitative measurements. The exclusion criteria: were animal studies, case reports with <10 participants, non-muscle assessments, and non-English publications.

Data Extraction and Analysis

Two investigators independently extracted data on study characteristics, elastography methodology, muscle groups, and statistical outcomes. Quality assessment was performed using the Newcastle- Ottawa Scale and QUADAS-2. A meta-analysis was conducted using random-effects models, with heterogeneity assessed using I² statistics.

Results

Study Characteristics

42 studies with 11, 025 participants were identified using the PRISMA (Figure 1, Table 1). The included studies utilized various elastography techniques across diverse populations and muscle groups (25-34). Mean age: 65.3±12.8 years, 58.7% female. Geographic distribution: Europe (32%), Asia (28%), North America (24%), and others (16%). A quality assessment of the studies showed that 43 % were of high quality, 40% of moderate quality, and 17 % of low quality.

Biomedical Science &, Research

Figure 1:PRISMA Flowchart for Systematic Review and Meta-Analysis of Elastography in Muscle Health Assessment.

Biomedical Science &, Research

Table 1:Study Characteristics.

Meta-Analysis Results

The mean age of the study revealed mean age: 65.3±12.8 years (range: 18-94 years), and 58.7% were female. The geographic distribution revealed that 32% of the studies were from Europe, (28%) from Asia, (24%) from North America, and Others were (16% from). The equipment distribution was (34%) Supersonic Aixplorer, (28%) GE Logic, (16%) Siemens Acuson. The study revealed an Intraclass Correlation Coefficient (ICC) of 0.82-0.96, with a Coefficient of Variation (CV) of 7.6% (relaxed muscle); the Standard Error of measurement was 1.2-2.8 kPa. The minimal detectable change was 6-10% (relaxed) and 15-16 % (stretched) (Table 2). The forest plot for meta-analysis of the random size effects of log odds ratio showed consistent positive effects across different study designs, with high-quality studies showing the most reliable evidence for elastography’s diagnostic accuracy in muscle health assessment. (Figure 2a) There was a symmetrical distribution of studies that were relatively evenly distributed around a pooled estimate of 1.15. Nearly all studies favored elastography, with an OR of 43.2, with most of the studies to the left of the mean.A funnel plot for bias estimation (Figure 2b ) showed a symmetric Distribution of Studies around the pooled estimate, with most high-quality studies clustered near the top (low SE), indicative of high precision, and nearly all studies favoring elastography (OR>1.0).The diagnostic performance test showed an AUC of 0.951 (95% CI: 0.923-0.973), a sensitivity of 85.2% (95% CI: 79.1-90.1%), a specificity of 91.4% (95 % CI: 86.8-94.8%), and a diagnostic odds ratio of 43.2. The calculated Reliability had an ICC: 0.82-0.96 (intra-session), 0.66-0.74 (inter-session). Coefficient of Variation: 7.6% (relaxed muscle). Heterogeneity: I² = 68 %; Cochran’s Q: P <0.001; robustness index = 0.92. Publication Bias: Egger’s test, P = 0.081 (non-significant). For aging a positive correlation with stiffness (r=+0.48, p<0.001) was seen, increasing from 12.8±2.9 kPa (18-30 years) to 18.2±4.1 kPa (>80 years). For a reduced stiffness pattern was observed (8.5±2.1 kPa vs. 18.2±4.1 kPa in controls, p<0.001) with negative correlation (r = -0.52, p<0.001). (Figure 3, Table 3). There were significant gender differences seen with males showing higher stiffness: rectus femoris 15.8±3.4 kPa vs. 13.2±2.9 kPa in females (p<0.001). Asian populations showed 15-20% lower baseline values than European populations [23,24]. The diagnostic Accuracy for Sarcopenia Detection was determined for both individual and multiparametric models. A) Analysis of the diagnostic performance of individual Elastography Parameters revealed varying accuracy levels for different parameters, with an AUC of 0.81-0.94 (Figure 3b, Table 4). Optimal cut-offs observed were for Gastrocnemius 10.8 kPa (sensitivity 73.2%, specificity 82.1%), Rectus femoris 12.3 kPa (sensitivity: 76.8%; specificity: 79.4%). B) The combined model parameters had a sensitivity of 84.5% and a specificity of 90.8 %. Strong correlations were also observed in the intramodality comparisons: SWE vs. DXA muscle mass (r = 0.67, p<0.001), SWE vs. BIA muscle mass (r = 0.54, p<0.001), SWE vs. grip strength (r = 0.58, p<0.001), SWE vs. gait speed (r = 0.43, p<0.001), SWE vs. chair stand test (r = 0.51, p<0.001) (35-40). Even in treatment response monitoring, elastography was seen to be more cost-effective than other contemporary modalities (Table 4).

Biomedical Science &, Research

Figure 2a:Forest plot of diagnostic Odds Ratios for sarcopenia detection.

Biomedical Science &, Research

Figure 2b:Funnel plot for assessing publication bias.

Biomedical Science &, Research

Figure 3a:Regression plot of age-related changes in Muscle Stiffness: Normal aging vs. sarcopenia.

Biomedical Science &, Research

Figure 3b:ROC Curves Analysis for Elastography Diagnostic Performance.

Biomedical Science &, Research

Table 2:Demographic and Reliability Parameters of the Study.

Biomedical Science &, Research

Table 3:Gastrocnemius Muscle Stiffness (kPa) - Normal Aging vs. Sarcopenia.

Biomedical Science &, Research

Table 4:Diagnostic Performance Comparison and Cut-off Values Muscle Stiffness Cut-off Values and Diagnostic Performance.

Discussion

The technical foundations of shear wave elastography have been extensively validated across different equipment platforms and measurement protocols [22]. Modern elastography systems demonstrate excellent reproducibility and accuracy in quantifying muscle mechanical properties with the ability to differentiate between active and passive muscle states. The evolution from traditional ultrasound to advanced elastography techniques represents a paradigm shift in non-invasive muscle assessment [23,24]. Population- specific considerations are crucial for clinical implementation. Asian populations consistently demonstrate different baseline elasticity values compared to European and North American cohorts, with variations of 15-20% observed across different muscle groups [23,24]. These ethnic differences likely reflect genetic variations in muscle fibre composition, collagen content, and overall muscle architecture patterns, which must be considered when establishing diagnostic thresholds. Studies have successfully applied these techniques to evaluate gastrocnemius stiffness in elderly populations [25-27], assessed quadriceps function in diabetes patients [28], examined lower extremity muscle properties in fall risk assessment [29], and investigated respiratory muscle function through diaphragmatic evaluation [30-33]. This broad applicability underscores the potential of elastography to become a standard component of comprehensive muscle health evaluation. Technical validation studies have established robust measurement protocols and reference standards across multiple muscle groups and patient populations [34-40]. The reliability coefficients consistently exceed 0.80 across different operators, sessions, and equipment types, supporting the clinical utility of these measurements in both research and clinical practice. This comprehensive meta-analysis demonstrated elastography as a transformative advancement in muscle health assessment [41,42]. Diagnostic performance (AUC = 0.951) significantly exceeded the established thresholds for clinical biomarkers [43,44]. A diagnostic odds ratio of 43.2 indicates individuals with abnormal findings are 42 times more likely to have sarcopenia [45]. The key finding is the ability of elastography to differentiate between normal aging and sarcopenia [46,47]. Normal aging showed a positive correlation with stiffness (r = +0.48), while sarcopenia showed a negative correlation (r =-0.52). This provides robust clinical decision-making framework with effect size of 2.8 [48,49]. Age-related changes in muscle structure and function have been extensively documented, showing a progressive decline in muscle mass, strength, and quality [50-52]. Individuals with stiffness >16 kPa demonstrated 90 % 5-year functional independence, while those with stiffness <12 kPa show 45-60% independence without intervention, improving to 70-85% with treatment [50,51]. The global consensus on sarcopenia emphasizes the importance of early detection and intervention strategies. Measurement reliability (ICC 0.82-0.96) met clinical implementation standards [52,53]. A coefficient of variation of 7.6% supports immediate deployment. Treatment monitoring showed a 23% improvement in detection within 16 weeks vs. 12-16 weeks for traditional methods [54,55]. The cost-effectiveness analysis showed $12,500 per QALY, which is well below the established thresholds. Implementation reduces emergency visits (35%), readmissions (28 %), and skilled nursing placements (45%) [56,57]. Non-significant publication bias (Egger’s p = 0.073), symmetric funnel plot, and robustness index of 0.92 confirm validity. Despite moderate heterogeneity (I² = 68%), the sensitivity analysis showed stability [58,59]. Evidence supports immediate implementation in geriatric units (94% negative predictive value), rehabilitation centers (78% treatment prediction), and research settings (ICC >0.80) [60,61].

Limitations

The use of elastography for muscle health has moderate heterogeneity, reflecting population diversity, focus on lower extremity muscles, and equipment requirements for implementation [62,63].

Conclusions

This analysis of 42 studies with 11,025 participants established elastography as a transformative tool with Grade A evidence for clinical implementation [64,65] and had superior performance, with AUC = 0.951, sensitivity = 85.2%, and specificity = 91.4%. It also shows excellent reliability (ICC >0.80 across conditions [66,67] with potential clinical utility in distinguishing normal aging from sarcopenia [68,69] and, at the same time, shows compelling economic benefits [70,71]. Elastography muscle assessment for treatment monitoring also has potential superior therapeutic response detection [72,73] and can enable precision medicine in muscle health assessment, significantly enhancing the early detection, monitoring, and management of sarcopenia globally [74-84].

Funding

None

Conflict of Interest

None

Acknowledgement

None

References

Sign up for Newsletter

Sign up for our newsletter to receive the latest updates. We respect your privacy and will never share your email address with anyone else.